Skip to main content

Table 2 Description of the patients who had early post-operative ECMO by E-CPR or non-E-CPR indication

From: Predictors and outcomes of early post-operative veno-arterial extracorporeal membrane oxygenation following infant cardiac surgery

Variable

E-CPR

n = 10

Non-E-CPR

n = 10

p value

Demographic variables

 Sex (male)

6(60%)

7(70%)

1.000

 Birth gestation (weeks)

38.0 (1.9)

38.8 (1.3)

0.519

 Birth weight (grams)

3141.4 (596.7)

3190.5(334.5)

0.823

Cardiac defecta

 RACHS-1 score

6 [4, 6]

4 [4, 6]

 

 HLHS

3 (30%)

3 (30%)

 

 HLHS variant

3 (30%)

1 (10%)

 

 TAPVD

1 (10%)

1 (10%)

 

 Pulmonary atresia

0 (0%)

1 (10%)

 

 Tricuspid atresia (1 with hypoplastic arch)

2 (20%)

0 (0%)

 

 D-TGA

1 (10%)

2 (20%)

 

 Other

0 (0%)

2 (20%)

 

 Year of admission

2009(3.6)

2008(3.2)

0.519

 Age (days) at time of ECMO

13.5(10.0)

11.9(6.8)

0.679

 Chromosomal abnormality

0 (0%)

2 (20%)

0.474

Operating room variables

 Cardiopulmonary bypass time (minutes)

n = 10

n = 9

0.837

145.5(84.6)

137.6(80.6)

 Aortic cross-clamp time (minutes), n = 18

n = 10

n = 8

0.756

65.0(48.8)

72.0(43.6)

 

 Deep hypothermic circulatory arrest time (minutes), n = 15

n = 8

n = 7

0.867

24.4(19.0)

25.9(13.7)

 Highest vasoactive-inotrope score

24.9(17.4)

48.0(50.4)

0.199

 Highest vasoactive-inotrope score > 30

2(20%)

4(40%)

0.628

 Highest epinephrine dose (for > 30 min; μg/kg/min)

0.15(0.13)

0.37(0.50)

0.214

 Highest epinephrine dose > 0.3 μg/kg/min

1(10%)

2(20%)

1.000

 Highest norepinephrine dose (for > 30 min; μg/kg/min)

0.03(0.07)

0.04(0.10)

0.749

 Highest dobutamine dose (μg/kg/min)

0.5(1.6)

1.0(3.2)

0.660

 Highest dopamine dose (μg/kg/min)

1.9(3.0)

3.7(4.2)

0.277

 Highest milrinone dose (μg/kg/min)

0.48(0.28)

1.0(2.3)

0.427

 Highest lactate once off CPB

7.1(2.3)

6.3(3.5)

0.541

 Lowest pH once off CPB

7.29(0.05)

7.27(0.11)

0.555

 Calcium bolus given

9(90%)

8(80%)

1.000

 Steroids given

9(90%)

8(80%)

1.000

 Open sternum from operating room

8(80%)

9(90%)

1.000

 Need to re-institute CPB

n = 10

n = 9

0.303

3(30%)

1(11%)

Post-operative day 1 variables

 PRISM III score

21.1 (6.5)

19.5 (6.5)

0.588

 Time to ECMO after admission to PCICU (hours)

11.2(8.5)

13.7(14.2)

0.631

 Highest lactate (mmol/L)

8.6(4.7)

7.7(5.1)

0.712

 Highest lactate > 6 mmol/L

7(70%)

5(50%)

0.650

 Lowest pH

7.28(0.05)

7.25(0.09)

0.343

 Lowest base deficit

− 5.7(3.1)

− 4.4(4.1)

0.418

 Lowest PaO2 (mmHg)

46.5(20.5)

54.6(47.2)

0.624

 Highest creatinine (μmol/L)

61.3(25.4)

65.4(31.7)

0.753

 Open sternum at any point on day 1

9(90%)

10(100%)

1.000

 Highest vasoactive-inotrope score

18.4(8.8)

55.6(43.3)

0.024

 Highest vasoactive-inotrope score > 30

0(0%)

7(70%)

0.003

 Highest epinephrine dose (μg/kg/min)

0.10(0.06)

0.32(0.33)

0.060

 Highest epinephrine dose > 0.3 μg/kg/min

0(0%)

3(30%)

0.211

 Highest norepinephrine dose (μg/kg/min)

0.006(0.019)

0.06(0.10)

0.103

 Highest dobutamine dose (μg/kg/min)

0

0.8(2.5)

0.343

 Highest dopamine dose (μg/kg/min)

2.3(4.2)

3.2(4.9)

0.685

 Highest milrinone dose (μg/kg/min)

0.50(0.36)

0.35(0.32)

0.326

Indication for ECMO

 Cardiac tamponade

2(20%)

 

 Low cardiac output syndrome

10(100%)

 

 Hypoxia

1(10%)

 

 Dysrhythmia

0(0%)

 

 Cardiopulmonary resuscitation done (excluding E-CPR)

0(0%)

2(20%)

0.474

 Cardiopulmonary resuscitation time (including E-CPR; minutes)

33(6)

n = 2

0.797

9(7)

 Other peri-operative period variables

 Transesophageal echocardiogram done in PCICU

6(60%)

10(100%)

0.087

 Cardiac catheterization performed post-operatively

5(50%)

4(40%)

1.000

 Residual defect found: requiring return to operating room or catheterization laboratory

3(30%)

5(50%)

0.650

 Seizures

1 (10%)

3 (30%)

0.582

 Dialysis

3(30%)

5(50%)

0.650

 Steroids started for low cardiac output syndrome prior to ECMO

3(30%)

7(70%)

0.179

Outcomes

 Duration of ECMO (hours)

282(304)

207(125)

0.484

 Peri-operative ventilation days

46(30)

46(76)

0.994

 Intensive care days post-operatively

38(137)

33(46)

0.782

 Total hospital days

73(52)

42(41)

0.154

 Death < 10 days post-operatively

1(10%)

3(30%)

0.582

 Death ≤ 30 days post-operatively

2(20%)

5(50%)

0.350

 Death by hospital discharge

3(30%)

5(50%)

0.650

 Death by 2 years of age

4 (40%)

7 (70%)

0.178

 General Adaptive Composite score on the ABAS-II

n = 6

n = 3

0.756

69.8 (14.3)

69.3 (12.5)

General Adaptive Composite score < 70 on ABAS-II

4 (66%)

1 (33%)

0.961

  1. Data are given as n (%), mean (standard deviation). p value is for Fisher’s exact test (categorical data) or independent samples two-sided t test (continuous data)
  2. ABAS Adaptive Behavior Assessment System, CPB cardiopulmonary bypass, E-CPR extracorporeal cardiopulmonary resuscitation, ECMO extracorporeal membrane oxygenation, HLHS hypoplastic left heart syndrome, LVOTO left ventricle outflow tract obstruction, PCICU pediatric cardiac intensive care unit, PRISM III Score pediatric risk of mortality score, RACHS-1 risk adjustment for congenital heart surgery score, TAPVD total anomalous pulmonary venous drainage, TGA transposition of the great arteries, VSD ventricular septal defect
  3. aSurgery performed was as follows: Norwood-Sano for n = 6 HLHS, n = 2 HLHS variants, and n = 1 tricuspid atresia; Norwood-BT for n = 1 HLHS variant; TAPVD repair for n = 2 TAPVD; right ventricle to pulmonary artery conduit with closure of VSD for n = 1 pulmonary atresia; central shunt for n = 1 HLHS variant; pulmonary artery banding for n = 1 tricuspid atresia; arterial switch with repair of VSD, or atrial septal defect and LVOTO, or atrial septal defect, VSD, right ventricle muscle bundles, and LVOTO for n = 3 d-TGA; right ventricle outflow tract obstruction resection and pulmonary valve plasty for n = 1 poly-valvular disease with Noonan’s syndrome; Ross-Konno procedure for n = 1 with complex LVOTO (sub-aortic stenosis, aortic valve stenosis, hypoplastic aortic arch with coarctation)